Last reviewed · How we verify

Amidephrine (amidefrine)

unknown active ✓ Verified May 2026

Amidephrine (generic name: amidefrine) is a amidefrine drug. It is currently in unknown development.

Amidephrine works by stimulating the sympathetic nervous system, which can increase heart rate and blood pressure.

Amidephrine is a small molecule. It is also known by several synonyms, including 5190, Amidephrine Mesilate, Amidephine, and Amidephine Mesilate.

At a glance

Generic nameamidefrine
Drug classamidefrine
TargetAdrenergic receptor alpha-1, Adrenergic receptor alpha-2
Therapeutic areaNeuroscience
Phaseunknown

Mechanism of action

Imagine your body's 'fight or flight' response, where your heart beats faster and your blood pressure rises to help you react quickly to a threat. Amidephrine is thought to trigger this response by stimulating the nerves that control these functions. This can be useful in certain medical situations, but more research is needed to understand its effects and potential uses.

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Amidephrine

What is Amidephrine?

Amidephrine (amidefrine) is a amidefrine drug.

How does Amidephrine work?

Amidephrine works by stimulating the sympathetic nervous system, which can increase heart rate and blood pressure.

What is the generic name of Amidephrine?

amidefrine is the generic (nonproprietary) name of Amidephrine.

What drug class is Amidephrine in?

Amidephrine belongs to the amidefrine class. See all amidefrine drugs at /class/amidefrine.

What development phase is Amidephrine in?

Amidephrine is in unknown.

What does Amidephrine target?

Amidephrine targets Adrenergic receptor alpha-1, Adrenergic receptor alpha-2 and is a amidefrine.

Related

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing